News

Latest news

15th September 2022

Sequana Medical announces H1 2022 results and provides business update

13th September 2022

SYNERGIA MEDICAL SUCCESSFULLY RAISES SERIES B FUNDING OF €9 MILLION

29th August 2022

Alexandra Clyde appointed to Sequana Medical Board of Directors

Acticor Biotech obtains "PRIME" status from the European Medicines Agency for glenzocimab in the treatment of stroke

Doug Kohrs appointed to Sequana Medical Board of Directors

Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update

Acticor Biotech announces the issuance of a patent in Europe for glenzocimab, its innovative product for the treatment of cardiovascular emergencies

Newton Biocapital is one of the 8 VC Firms Certified for AMED Funding Project to Boost Pharma Ecosystem

Newton Biocapitalは、国立研究開発法人日本医療研究開発機構（AMED）の令和４年度「創薬ベンチャーエコシステム強化事業」において、革新的な技術開発を行う創薬ベンチャーの支援に適した認定ベンチャーキャピタルとして採択されましたのでお知らせします。

1
2
3
4